Business ❯Pharmaceutical Industry ❯Novo Nordisk ❯Eli Lilly

Market Trends

Elon Musk and RFK Jr. Clash Over Weight-Loss Drug Policies

The debate over GLP-1 drugs like Ozempic intensifies as Musk advocates for affordability while RFK Jr. emphasizes lifestyle changes.

Government Plans Dominate Coverage for Costly Weight-Loss Drugs